Singapore markets close in 4 hours 7 minutes
Straits Times Index
3,269.59 -30.45 (-0.92%) Nikkei
38,194.06 -641.04 (-1.65%) Hang Seng
18,410.20 -69.17 (-0.37%) FTSE 100
8,313.67 +100.18 (+1.22%) Bitcoin USD
62,608.68 -765.45 (-1.21%) CMC Crypto 200
1,297.97 -67.15 (-4.92%)
AXSM May 2024 67.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:56AM EDT. Market open.
| Previous close | 10.20 |
| Open | 10.20 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 67.50 |
| Expiry date | 2024-05-17 |
| Day's range | 10.20 - 10.20 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksAxsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Axsome's (AXSM) bottom line declines year over year in the first quarter. Strong sales of Auvelity drive revenues.
Insider MonkeyAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.44233 EPS, expectations were $-1.2. Axsome Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
- GuruFocus.com
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
Discover how Axsome Therapeutics achieved a 160% revenue increase and navigated heightened R&D and operational costs in Q1 2024.
© 2024 Yahoo. All rights reserved.